Annals of the New York Academy of SciencesVolume 756, Issue 1 p. 113-116 Evidence for an Endogenous Superantigen Deleting Human Vβ2 Positive T-Lymphocytes ARTHUR W. BOYLSTON, ARTHUR W. BOYLSTON Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorGILLIAN R. CLARKE, GILLIAN R. CLARKE Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorFIONA C. LANCASTER, FIONA C. LANCASTER Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorHUGH REYBURN, HUGH REYBURN Institute of Molecular Medicine Oxford University Oxford, United KingdomSearch for more papers by this author ARTHUR W. BOYLSTON, ARTHUR W. BOYLSTON Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorGILLIAN R. CLARKE, GILLIAN R. CLARKE Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorFIONA C. LANCASTER, FIONA C. LANCASTER Department of Molecular Medicine Leeds University Leeds LS9 TTF, United KingdomSearch for more papers by this authorHUGH REYBURN, HUGH REYBURN Institute of Molecular Medicine Oxford University Oxford, United KingdomSearch for more papers by this author First published: July 1995 https://doi.org/10.1111/j.1749-6632.1995.tb44494.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume756, Issue1T‐Cell Receptor Use in Human Autoimmune DiseasesJuly 1995Pages 113-116 RelatedInformation